Zhang Wei, Liu Edgar S L, Fu Jun, Tian Hai-Mei, Wu Ying-Jye, Pang Shiu-Fun
Detection Center of Tumor Biology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, Hong Kong.
Invest New Drugs. 2006 May;24(3):181-7. doi: 10.1007/s10637-005-2633-6.
CKBM is a product composed of natural ingredients and had been shown to possess certain anti-cancer effects in vitro and in vivo. The aim of the present study is to analyze the chemosensitivity in the treatment of primary colon, breast, gastric and bladder cancer cells by CKBM. A total of 77 patients with cancers of breast, colon, stomach or bladder were included in the present study. Primary cancer cells were isolated from the surgical removed tumors and treated with various dosages of CKBM for 5 days. ATP is then extracted and measured by luminescence assay. CKBM treatment inhibited primary colon, breast, gastric and bladder cancer growth dose-dependently. The IC values were smaller from tumor cells at early stages, when compared with the ones at later stages. The present study strongly indicated that CKBM exerted cytotoxic effect on primary cancer cells.
CKBM是一种由天然成分组成的产品,已被证明在体外和体内具有一定的抗癌作用。本研究的目的是分析CKBM对原发性结肠、乳腺、胃和膀胱癌细胞治疗的化学敏感性。本研究共纳入77例乳腺癌、结肠癌、胃癌或膀胱癌患者。从手术切除的肿瘤中分离出原发性癌细胞,并用不同剂量的CKBM处理5天。然后提取ATP并通过发光测定法进行测量。CKBM处理剂量依赖性地抑制原发性结肠、乳腺、胃和膀胱癌细胞的生长。与晚期肿瘤细胞相比,早期肿瘤细胞的IC值较小。本研究有力地表明,CKBM对原发性癌细胞具有细胞毒性作用。